نتایج جستجو برای: cardiovascular disease cvd

تعداد نتایج: 1590038  

Journal: :Archives of clinical and biomedical research 2023

Introduction: Cardiovascular disease (CVD) is a group of diseases that include both the heart and blood vessels, thereby including coronary (CHD) artery (CAD), acute syndrome (ACS) among several other conditions.

Journal: :JAMA 2014
Emanuele Di Angelantonio Pei Gao Hassan Khan Adam S Butterworth David Wormser Stephen Kaptoge Sreenivasa Rao Kondapally Seshasai Alex Thompson Nadeem Sarwar Peter Willeit Paul M Ridker Elizabeth L M Barr Kay-Tee Khaw Bruce M Psaty Hermann Brenner Beverley Balkau Jacqueline M Dekker Debbie A Lawlor Makoto Daimon Johann Willeit Inger Njølstad Aulikki Nissinen Eric J Brunner Lewis H Kuller Jackie F Price Johan Sundström Matthew W Knuiman Edith J M Feskens W M M Verschuren Nicholas Wald Stephan J L Bakker Peter H Whincup Ian Ford Uri Goldbourt Agustín Gómez-de-la-Cámara John Gallacher Leon A Simons Annika Rosengren Susan E Sutherland Cecilia Björkelund Dan G Blazer Sylvia Wassertheil-Smoller Altan Onat Alejandro Marín Ibañez Edoardo Casiglia J Wouter Jukema Lara M Simpson Simona Giampaoli Børge G Nordestgaard Randi Selmer Patrik Wennberg Jussi Kauhanen Jukka T Salonen Rachel Dankner Elizabeth Barrett-Connor Maryam Kavousi Vilmundur Gudnason Denis Evans Robert B Wallace Mary Cushman Ralph B D'Agostino Jason G Umans Yutaka Kiyohara Hidaeki Nakagawa Shinichi Sato Richard F Gillum Aaron R Folsom Yvonne T van der Schouw Karel G Moons Simon J Griffin Naveed Sattar Nicholas J Wareham Elizabeth Selvin Simon G Thompson John Danesh

IMPORTANCE The value of measuring levels of glycated hemoglobin (HbA1c) for the prediction of first cardiovascular events is uncertain. OBJECTIVE To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. DESIGN, SETTING, AND PARTICIPANTS Analysis of individual-partici...

Journal: :Pharmacophore 2021

Cardiovascular disease (CVD) and its complications are the most common causes of mortality morbidity worldwide. It is shown that patients with myocardial infarctions (MIs) have high platelets activation aggregation rates which lead to atherothrombosis after rupture an unstable atherosclerotic plaque. Therefore, antiplatelet therapy has become important part secondary prevention cardiovascular d...

2010
Katarzyna Bergmann

Cardiovascular disease (CVD), such as coronary heart disease (CHD), is the most frequent cause of death worldwide, especially in developed countries. The latest recommendations of European and American Cardiological Associations emphasize the role of non-HDL cholesterol (non-HDL-C) in evaluating the risk of CVD. Although this parameter has a lot of advantages, it is rarely used by general pract...

2014
Divya Srivastava Tanmay Tiwari Sandeep Sahu Abhilash Chandra Sanjay Dhiraaj

Cardiovascular disease (CVD) is an important comorbidity of chronic kidney disease, and reducing cardiovascular events in this population is an important goal for the clinicians who care for chronic kidney disease patients. The high risk for CVD in transplant recipients is in part explained by the high prevalence of conventional CVD risk factors (e.g., diabetes, hypertension, and dyslipidemia) ...

2013
Han Li Shixiang Wang

Cardiovascular disease (CVD) is a most common complication and a chief cause of death in pa‐ tients with end stage renal disease (ESRD) accounting for 45% to 50% of causes of death in ESRD patients. In ESRD patients, mortality due to CVD is 10~30 times higher than in the general pop‐ ulation. 80% patients on maintenance homodialysis (MHD) had cardiovascular complication. In Chinese patients, th...

Journal: :Journal of the American College of Cardiology 2010
Jeffrey S Berger Courtney O Jordan Donald Lloyd-Jones Roger S Blumenthal

Cardiovascular disease is the number 1 cause of death in the western world and 1 of the leading causes of death worldwide. The lifetime risk of atherosclerotic cardiovascular disease (CVD) for persons at age 50 years, on average, is estimated to be 52% for men and 39% for women, with a wide variation depending on risk factor burden. Assessing patients' cardiovascular risk may be used for the ta...

Journal: :iranian journal of public health 0
masoumeh sadeghi ali akbar haghdoost abbas bahrampour mohsen dehghani

background: estimating the burden of non-communicable diseases particularly cardiovascular disease (cvd) is essential for health management and policymaking. in this paper, we used a regression model to estimate the future impact of demographic changes on the burden of cvd in iran during the next two decades. methods: disability-adjusted life years (daly) were used to estimate the future burden...

2009
Esther S.H. Kim Venu Menon

The Burden of Cardiovascular Disease in Women Cardiovascular disease (CVD) is the most common cause of death in American women and accounts for a full one-third of all deaths.1 Although the common perception may be that CVD affects mainly men, there is equal prevalence of this disease between the genders by the age of 40, and by the age of 60 more women than men are affected. More women than me...

Journal: :international journal of preventive medicine 0
danielle m. lambrick lee stoner james faulkner michael j hamlin

although cardiovascular disease (cvd) is typically associated with middle- or old-age, the atherosclerotic process often initiates early in childhood and is occurring at an increasing rate. there is a consensus that changes in life-style have driven the current epidemic. adverse changes in physical activity, nutrition, and sleep behavior have been strongly linked to the development of a host of...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید